Iranian Journal of Neurology 2017. 16(4):.

Analysis of apolipoprotein E genetic variation in Alzheimer disease patients referred to Imam Reza Clinic, Iran, in 2015
Amir Reza Ghayeghran, Maryam Akbarshahi, Zivar Salehi, Ali Davoudi-Kiakalayeh

Abstract


-

Keywords


Alzheimer Disease; Apolipoprotein E; Genetic Variation

References


Sadigh-Eteghad S, Talebi M, Farhoudi M. Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer’s disease. A meta-analysis Neurosciences (Riyadh). 2012;17(4):321-6.

Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature Reviews Neurology. 2013;9(2):106-18.

Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA. Sleep Modifies the Relation of APOE to the Risk of Alzheimer Disease and Neurofibrillary Tangle Pathology. JAMA neurology. 2013;70(12).

Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park Y, et al. Age-at-onset in late onset Alzheimer disease is modified by multiple genetic loci. JAMA neurology. 2014;71(11):1394.

Rogan S, Lippa CF. Alzheimer's disease and other dementias: a review. American journal of Alzheimer's disease and other dementias. 2002;17(1):11-7.

Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-6.

Blennow K dLM, Zetterberg H. Alzheimer’s disease. Lancet. 2006(368):387–403.

Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V, et al. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. Archives of neurology. 2006;63(9):1307-11.

Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS β-amyloid in Alzheimer’s disease. Science. 2010;330(6012):1774-.

Rocchi A, Pellegrini S, Siciliano G, Murri L. Causative and susceptibility genes for Alzheimer’s disease: a review. Brain research bulletin. 2003;61(1):1-24.

Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261(5123):921-3.

Shahsavar F, Sabooteh T, Jafarzadeh M. Distribution of ApoE polymorphisms in the Lur population. yafte. 2014; 15 (5) :5-12

Sabbagh MN, Malek-Ahmadi M, Dugger BN, Lee K, Sue LI, Serrano G, et al. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease. BMC neurology. 2013;13(1):1.

Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Jama. 1997;278(16):1349-56.

Ellis R, Olichney JM, Thal L, Mirra S, Morris J, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease The CERAD experience, part XV. Neurology. 1996;46(6):1592-6.

Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain research. 1991;541(1):163-6.

Altmann A, Tian L, Henderson VW, Greicius MD. Sex modifies the APOE‐related risk of developing Alzheimer disease. Annals of neurology. 2014;75(4):563-73.

Zhou X, Miao H, Rausch WD, Long M, Luo X, Yu H, et al. Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations. Psychogeriatrics. 2012;12(2):83-7.

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature genetics. 2009;41(10):1088-93.

Lambert J, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. European Alzheimer’s Disease Initiative Investigators. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1094-9.

Isbir T, Agaçhan B, Yilmaz H, Aydin M, Kara I, Eker E, et al. Apolopoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease. American journal of Alzheimer's disease and other dementias. 2001;16(2):77-81.

Hu C-J, Sung S-M, Liu H-C, Chang J-G. Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese. Journal of the neurological sciences. 1998;157(2):158-61.

Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annual review of genomics and human genetics. 2000;1(1):507-37.

Finch CE, Shams S. Apolipoprotein E and sex bias in cerebrovascular aging of Men and mice. Trends in Neurosciences. 2016;39(9):625-37.

Ventakaramana P, Chengal R, Ferrell R. Apolipoprotein E polymorphism in two populations of Andru Pradesh. Ind J Hum Genet. 2002;3:1-5.

Gavett BE, John SE, Gurnani AS, Bussell CA, Saurman JL. The Role of Alzheimer’s and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer’s Disease. Journal of Alzheimer's Disease. 2015;49(2):531-45.

Paz-y-Mino C, Carrera C, López-Cortés A, Munoz MJ, Cumbal N, Castro B, et al. Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease. The American journal of the medical sciences. 2010;340(5):373-7.

Wang L, Roe CM, Snyder AZ, Brier MR, Thomas JB, Xiong C, et al. Alzheimer disease family history impacts resting state functional connectivity. Annals of neurology. 2012;72(4):571-7.

Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Archives of Neurology. 2011;68(10):1313-9.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.